India caps trade margins on non-scheduled anti-cancer drugs at 30%

Statements (4)

1. ▲ Bullish

   The government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially cutting prices by 20–70% and saving patients ₹2,500 crore annually.

   livemint.comOct 9, 2026 07:19 UTCHigh importance
2. ▲ Bullish

   Hospital stocks rose to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%.

   economictimes.indiatimes.comOct 9, 2026 05:44 UTCHigh importance
3. ▲ Bullish

   The government capped trade margins on non-scheduled anti-cancer drugs at 30%.

   economictimes.indiatimes.comOct 9, 2026 05:44 UTCHigh importance
4. ● Neutral

   The Centre has decided to cap trade margins for all non-scheduled anti-cancer drugs at 30 per cent of the MRP.

   business-standard.comOct 9, 2026 04:33 UTCHigh importance